IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intra Cellular Therapies Inc

CUSIP: 04611X101 | 1 institutional holders

Quarters

Q2 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2017

Opaleye Management Inc.85,000
0.0% of portfolio›$1.1K
StyleTurnoverLocationFiled
Opaleye Management Inc.
85,000$1.1K0.0%Agg GrowthMediumBoston, MA2017-08-14